EORTC SPECTA-AYA: a unique molecular profiling platform for adolescents and young adults with cancer in Europe
Authorsde Rojas, T
Van der Graaf, W
AffiliationEORTC Headquarters, Brussels, BelgiumSarcoma Unit, Mannheim University Medical Center, University of Heidelberg, Mannheim, Germany
MetadataShow full item record
AbstractFor most adolescent and young adult (AYA) cancers, age-specific molecular features are poorly understood. EORTC-SPECTA, an academic translational research infrastructure for biomaterial collection, will explicitly recruit AYA patients and will therefore collect empirical data to bridge the molecular gap between pediatric and adult oncology. The initial pilot study, activated in February 2019 across Europe, will recruit 100 AYA patients (aged 12-29?years) with newly diagnosed or relapsed high-grade gliomas and high-grade bone and soft tissue sarcomas. The primary objective of the pilot is to determine feasibility and recruitment rates. Formalin-fixed tumor tissue and whole blood from study participants will be prospectively collected with clinical data and stored centrally at the Integrated BioBank of Luxembourg. Whole exome sequencing of matched tumor and blood, and tumor RNA sequencing and DNA methylation profiling will be performed at the German Cancer Research Center, Heidelberg, Germany. Virtual central pathology review of scanned diagnostic slides will be undertaken by an international expert panel, and diagnostic material returned to the participating centers. A multidisciplinary molecular tumor board will release a clinically validated report to referring clinicians within 4-6?weeks after biopsy. SPECTA-AYA constitutes a major opportunity to gain knowledge about the tumor biology of this unique age group. It incorporates notable innovative aspects: AYA specificity, pan-European academic collaboration, centralized biobanking, comprehensive molecular profiling and virtual central pathology review, among others. SPECTA-AYA will help untangle the tumor particularities of AYAs with cancer and aims to improve their access to novel drugs and personalized medicine.
Citationde Rojas T, Kasper B, Van der Graaf W, Pfister SM, Bielle F, Ribalta T, et al. EORTC SPECTA-AYA: a unique molecular profiling platform for adolescents and young adults with cancer in Europe. Int J Cancer. 2019 Aug 29.
JournalInternational Journal of Cancer
- Collaboration and Networking.
- Authors: Husson O, Manten-Horst E, van der Graaf WT
- Issue date: 2016
- Clinical application of genomic profiling to find druggable targets for adolescent and young adult (AYA) cancer patients with metastasis.
- Authors: Cha S, Lee J, Shin JY, Kim JY, Sim SH, Keam B, Kim TM, Kim DW, Heo DS, Lee SH, Kim JI
- Issue date: 2016 Feb 29
- Survival of childhood and adolescent/young adult (AYA) cancer patients in Ireland during 1994-2013: comparisons by age.
- Authors: Alken S, Owens C, Gilham C, Grant C, Pears J, Deady S, O'Marcaigh A, Capra M, O'Mahony D, Smith O, Walsh PM
- Issue date: 2020 May 18
- Descriptive epidemiology and outcomes of bone sarcomas in adolescent and young adult patients in Japan.
- Authors: Fukushima T, Ogura K, Akiyama T, Takeshita K, Kawai A
- Issue date: 2018 Aug 18
- Treatment of adolescents and young adults (AYA) with cancer in a multidisciplinary setting: on the way to a highly specialized AYA unit.
- Authors: Bernig T, Jahn F, Witkowsky S, Huehn R, Hentschel A, Kegel T, Schmoll HJ, Körholz D
- Issue date: 2013 Nov